Sensius

Sensius is a medical technology company based in the Netherlands, founded in 2015. The company specializes in personalized thermotherapy aimed at improving cancer treatment outcomes, particularly for patients undergoing radiotherapy. Sensius develops a thermotherapy system that raises tumor temperatures to around 42°C, enhancing the effectiveness of traditional therapies like radiotherapy, chemotherapy, and immunotherapy while minimizing toxicity. The company initially focuses on head and neck cancer, with plans to expand into breast cancer and melanoma. Sensius offers precision thermotherapy devices for oncology clinics and provides integration support to align their technology with existing radiotherapy protocols. They collaborate with clinical teams worldwide to optimize treatment efficacy and improve patient quality of life. Sensius has gained regulatory attention with CE Mark and IDE filings underway, facilitating market access in Europe and the US. Their customer base includes cancer treatment centers and hospitals, aiming to enhance clinical outcomes and provide cost-effective solutions for healthcare providers.

• Employees 11
• Founded 2015